|
Organization |
| Founded in 2002, Concurrent Analytical Inc.
is a privately held Delaware C-Corporation. Concurrent
Analytical Inc. operates two commercial divisions, Nanopartz (www.nanopartz.com)
and Directed Bioflux (www.dbflux.com). |
|
X rays are a hoax.
-- New York Times headline, 1911
I think that there is a world market for
about five computers.
-- Thomas Watson, Chairman of IBM, 1943
640K [of memory] ought to be enough for anybody.
-- Bill Gates, CEO of Microsoft, 1981
The cloning of mammals…is biologically impossible.
-- Science, 1984
|
 |
About Us |
 |
Concurrent Analytical is developing the Ramanprobes
technology. This technology has been funded by the National Defense Center of Excellence for Research
in Ocean Sciences (CEROS) Defense Advanced Research Projects
Agency (DARPA), National Institute of Health (NIH), the National
Science Foundation (NSF), as well as private investment and commercial
sales. Through our research sponsors, we have raised over
$4M in grants and supported over $1.5M in sponsored University research.
|
|
Who We Are |
|
Officers and Board Members
 Shelley J. Coldiron, Ph.D.,
CEO and President,
shelley.coldiron@concana.com, was most recently Co-Founder,
Director, President & CEO of CombiSep, Inc. - With over 25 years
experience, Dr. Coldiron has a diverse background in instrumentation,
analytical chemistry, bioengineering, environmental chemistry and
entrepreneurism - serving in private, public and government sectors. Dr.
Coldiron was responsible for all operating aspects of CombiSep. CombiSep
has developed and is manufacturing analytical instrumentation for high
throughput screening and separations that will support the paradigm
shift that is occurring in drug discovery, combinatorial chemistry, high
throughput process chemistry and biochemistry, clinical chemistry and
proteomics. Dr. Coldiron raised over $6.5M in funds for CombiSep
from government grants, government loans, commercial loans, private
loans, and two rounds of private equity. Prior to founding CombiSep, she
was a Co-Founder, Director and President of Advanced Analytical
Technologies, responsible for all operating aspects of that firm until
August 1999 and successfully raised $3M in private equity to develop
food safety testing technologies. In total, she has raised over $9.5M in
funding for both companies that she co-founded.
 Christian L.
Schoen, Ph.D. Founder, VP Marketing and Product Development and CTO, cschoen@concana.com.
Dr. Schoen received his BSEE from UCLA, an MSEE from USC, and being
of Hawaiian descent, his
PhD from the University of Hawaii in 1992. He has over 25 years of laser
optical experience, more specifically in Raman spectroscopy. He has
worked at Hughes Aircraft, TRW, Lawrence Livermore
National Labs (LLNL), and on the faculty of the University of
Hawaii. He turned entrepreneur in 1994 when he founded Detection Limit Technology Inc., a company that
revolutionized portable Raman instrumentation. His success came
from combining his laser optical experience learned designing
military laser systems in the aerospace industry with his TRW fellowship
funded PhD work at the University of Hawaii in Raman Spectroscopy. His
current interest in nanotechnology came from his work with Surface
Enhanced Raman labels in conjunction with his laser Raman
instrumentation. His inventions have generated millions of dollars in sales, and he has been PI on more than
$7M in research grants. He is the inventor on three patents, the author of
eleven journal publications and ten conference proceedings, and has been
an invited speaker at PittCon. Besides being a successful
entrepreneur, Dr. Schoen played baseball at UCLA and later was a ranked,
professional triathlete. He is married and the father of three
teenage children.
|
History
Concurrent Analytical Inc.
was founded in 2002 with the express purpose
of developing SERS Raman labels with Raman
instrumentation. Among other
achievements, the combination of the
Nanoraman instrument with the SERS technology saw instant
success in sensitivity and specificity.
Since its founding,
Concurrent Analytical has made continuous
enhancements to the original technology.
Currently, the Ramanprobes system is
capable of attomolar detection of viruses in
blood in less than ten seconds.
The company is now a
complete multi-level manufacturing
operation with leading edge research and
development teams, and veteran customer
service and support.
|
|
